Gabriel Vidal, MD
Vascular Neurology · New Orleans, LANPI 1871788216
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $117,130 of the $166,888 with a category attached, or 70.2%. 20 manufacturers reported payments, led by Penumbra, Inc. at 55.3% of the total.
Across 258 payments — averaging $646.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$92K
- AstraZeneca$67K
- Stryker$5K
- Imperative Care, Inc$894
- Microvention, Inc.$805
- Johnson & Johnson$292
- plus $642 from 14 others
Across 13 payments — averaging $3014.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Microvention, Inc.$39K
What the payments were for
- Consulting fees$7,3184%
- Speaking & faculty fees$117,13070%
- Travel & lodging$33,43820%
- Food & beverage$9,0035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 123 | $92,251 |
| AstraZeneca(2 entities) | 59 | $66,514 |
| Stryker | 8 | $5,490 |
| Imperative Care, Inc | 21 | $894 |
| Microvention, Inc. | 20 | $805 |
| Johnson & Johnson(2 entities) | 5 | $292 |
| Siemens Medical Solutions USA, Inc. | 1 | $134 |
| Contego Medical, Inc | 1 | $130 |
| Medtronic(3 entities) | 4 | $78 |
| Portola Pharmaceuticals, LLC | 3 | $68 |
| Eisai Inc. | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Terumo Medical Corporation | 1 | $27 |
| Genentech USA, Inc. | 1 | $23 |
| AbbVie | 1 | $21 |
| GT Medical Technologies, Inc | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Amgen | 1 | $14 |
| Cardinal Health 200 LLC | 1 | $12 |
| UCB, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$65,995
- Penumbra System$53,369
- Smart Coil$26,425
- RED 72$6,337
- TREVO$5,422
- ACE$2,400
- Penumbra Coil 400$1,924
- Penumbra SMART Coil$436
- ZOOM 88-T LARGE DISTAL PLATFORM$268
- TRUFILL$215
- SOFIA 6F-131CM STR$145
- WEB Aneurysm Embolization System$145
- STENT$114
- LVIS JUNIOR$114
- TracStarLargeDistalPlatform$103
- Zoom88LargeDistalPlatform$103
- Zoom88_TLargeDitalPlatform$103
- ZoomReperfusionCatheter$103
- WEB$103
How this compares
Too few vascular neurology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in New Orleans
- Richard ZweiflerNew Orleans$5K
- Robert TrainorNew Orleans$824
- Kim LeeNew Orleans$407
- Uday Shanker NadimpallyNew Orleans$300
- Vijayakumar JavalkarShreveport$4K
- Pankaj SharmaShreveport$3K
- Roger KelleyShreveport$3K
- Himanshu ChokhawalaShreveport$3K
- Bryce CasteigneThibodaux$2K
- Ashok PoluBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.